MarketCap
Facebook
X
Telegram
Land |
 China |
IPO-Jahr |
2018 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
- |
Marktkapitalisierung |
$ 5.72 M |
EBITDA (LTM) |
$ 255 K |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-0.19 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Agenus
AGEN
|
$ 8.36 | 0.36 % | $ 249 M | Nasdaq Capital Market |  USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 31.8 | 0.88 % | $ 1.84 B | Nasdaq Global Select Market,SPB | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.18 | 1.75 % | $ 291 K | NYSE American | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.87 | 3.83 % | $ 224 M | Nasdaq Global Market | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 8.72 | 3.79 % | $ 587 B | Nasdaq Capital Market |  Britain |
 |
Aldeyra Therapeutics
ALDX
|
$ 1.17 | 4.88 % | $ 70.3 M | Nasdaq Global Select Market | USA |
 |
Alector
ALEC
|
$ 1.81 | 0.27 % | $ 186 M | Nasdaq Global Select Market,SPB | USA |
 |
Aligos Therapeutics
ALGS
|
$ 5.54 | 0.73 % | $ 54.8 M | Nasdaq Global Select Market | USA |
 |
Alkermes plc
ALKS
|
$ 41.75 | 2.98 % | $ 6.88 B | Nasdaq Global Select Market |  Irlanda |
 |
Allogene Therapeutics
ALLO
|
$ 1.5 | 0.32 % | $ 331 M | Nasdaq Global Select Market,SPB | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 219.72 | 0.84 % | $ 28.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.74 | 0.36 % | $ 241 M | Nasdaq Global Market | USA |
 |
ALX Oncology Holdings
ALXO
|
$ 1.22 | 1.08 % | $ 65.5 M | Nasdaq Global Select Market,SPB | USA |
 |
Amgen
AMGN
|
$ 403.04 | 0.07 % | $ 217 B | Nasdaq Global Select Market,SPB | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 25.43 | 0.32 % | $ 1.19 B | Nasdaq Global Select Market | USA |
 |
Amarin Corporation plc
AMRN
|
$ 12.35 | 0.31 % | $ 5.13 B | Nasdaq Global Market | Irlanda |
 |
Amneal Pharmaceuticals
AMRX
|
$ 20.3 | 1.15 % | $ 6.36 B | NYSE | USA |
 |
AnaptysBio
ANAB
|
$ 48.53 | 0.33 % | $ 1.41 B | Nasdaq Global Select Market,SPB | USA |
 |
Anika Therapeutics
ANIK
|
$ 19.1 | 0.28 % | $ 274 M | Nasdaq Global Select Market,SPB | USA |
 |
ANI Pharmaceuticals
ANIP
|
$ 72.18 | 0.43 % | $ 1.45 B | Nasdaq Global Market,SPB | USA |
 |
Annexon
ANNX
|
$ 4.19 | 1.7 % | $ 650 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 1.18 | 0.85 % | $ 24.3 M | NYSE American | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.7 | 0.16 % | $ 4.58 M | Nasdaq Global Select Market,SPB | USA |
 |
Aptevo Therapeutics
APVO
|
$ 1.78 | 0.85 % | $ 562 K | Nasdaq Capital Market | USA |
 |
Aquestive Therapeutics
AQST
|
$ 4.55 | 2.48 % | $ 487 M | Nasdaq Global Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 13.03 | 0.22 % | $ 357 M | Nasdaq Global Market,SPB |  Israel |
 |
Ardelyx
ARDX
|
$ 3.34 | 0.88 % | $ 805 M | Nasdaq Global Market | USA |
 |
argenx SE
ARGX
|
$ 919.21 | 1.28 % | $ 56.3 B | Nasdaq Global Select Market |  Niderland |
 |
MediWound Ltd.
MDWD
|
$ 13.52 | 0.59 % | $ 368 M | Nasdaq Global Select Market | Israel |
 |
Armata Pharmaceuticals
ARMP
|
$ 3.52 | 6.34 % | $ 128 M | NYSE American | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 25.16 | 0.3 % | $ 3.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Artelo Biosciences
ARTL
|
$ 3.68 | 0.25 % | $ 696 K | Nasdaq Global Select Market | USA |
 |
Arvinas
ARVN
|
$ 7.41 | 0.07 % | $ 525 M | Nasdaq Global Select Market,SPB | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 64.19 | 0.12 % | $ 8.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Assembly Biosciences
ASMB
|
$ 22.54 | 0.61 % | $ 253 M | Nasdaq Global Select Market,SPB | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 227.87 | 0.25 % | $ 13.8 B | Nasdaq Global Select Market |  Danmark |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.45 | 1.09 % | $ 22.1 B | Nasdaq Capital Market |  Australia |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.17 | 1.74 % | $ 36.5 M | NYSE American | USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.34 | 3.08 % | $ 20.2 M | Nasdaq Capital Market | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 9.48 | 12.06 % | $ 119 M | Nasdaq Global Select Market,SPB | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 15.83 | 0.49 % | $ 2.13 B | Nasdaq Global Market |  Canada |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.78 | 4.3 % | $ 474 M | Nasdaq Global Select Market | Britain |
 |
Atea Pharmaceuticals
AVIR
|
$ 5.13 | 0.59 % | $ 418 M | Nasdaq Global Select Market | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
$ 1.82 | 0.43 % | $ 155 M | Nasdaq Capital Market | USA |
 |
Axon Enterprise
AXON
|
$ 413.35 | 0.25 % | $ 32.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Axsome Therapeutics
AXSM
|
$ 179.25 | 0.73 % | $ 8.92 B | Nasdaq Global Market,SPB | USA |
 |
Aytu BioScience
AYTU
|
$ 2.07 | 0.93 % | $ 25.5 M | Nasdaq Capital Market | USA |
 |
BridgeBio Pharma
BBIO
|
$ 67.25 | 0.51 % | $ 12.9 B | Nasdaq Global Select Market,SPB | USA |
 |
BioCardia
BCDA
|
$ 1.04 | 1.96 % | $ 6.93 M | Nasdaq Global Select Market | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 8.17 | 0.62 % | $ 1.71 B | Nasdaq Global Select Market | USA |